Research area
Incretin, energy-use, and metabolic-signaling research.
Collection focus
Research materials for laboratories that value clear sourcing and dependable support.
Research-use catalog
GLP-3 (RT) Peptide is Azure’s catalog name for a retatrutide metabolic research peptide studied as a triple agonist at GIP, GLP-1, and…
NAD+ is a cellular coenzyme research compound central to redox biology, mitochondrial metabolism, sirtuin activity, and energy-transfer literature.
GLP-3 (RT) Pen – 40 mg is researched in research peptide comparison, with literature context focused on mechanism, pathway role, and evidence…
AICAR is an AMPK-pathway research compound used as a reference in cellular energy-sensing, glucose uptake, lipid metabolism, and exercise-mimetic literature.
Adipotide is a prohibitin-targeting peptidomimetic studied for adipose vasculature signaling in metabolic research, including preclinical and primate obesity literature.
AOD-9604 is a modified fragment of human growth hormone 176-191 studied in GH-fragment and lipid-metabolism signaling models.
SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.
MOTS-c is a mitochondrial-derived peptide studied in metabolic stress, AMPK-adjacent signaling, glucose metabolism, and cellular adaptation literature.
HGH is a somatotropin reference material used in growth hormone receptor, IGF-1 axis, protein-synthesis, and metabolic-signaling research.
Tesamorelin is a stabilized GHRH analog with published pharmacology and controlled-study literature on GH-axis signaling.
Mazdutide sits in the GLP-1 / glucagon dual-agonist research lane, where interest centers on incretin signaling, energy expenditure, and metabolic markers.
Tirzepatide is a dual GIP / GLP-1 receptor agonist reference point in metabolic research and comparative incretin pharmacology.
Vérification âge
This catalog is for adults reviewing laboratory research materials. Products are not for human or veterinary use.
Accès indisponible. Vous devez avoir 21 ans ou plus pour accéder à ce site.
